RNA Analysis Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

Description

The global RNA Analysis Market, valued at $15.99 billion in 2024, is poised to witness extraordinary growth. Driven by advancements in Real Time-PCR (qPCR) technology and a surge in COVID-19 diagnoses, the market is projected to grow at a CAGR of 17.3% from 2024 to 2031, reaching an impressive $48.89 billion by 2031.

Surge in Real Time-PCR (qPCR) Technology

Real Time-PCR (qPCR) technology stands out as the highest revenue-generating segment in the RNA Analysis Market. With a CAGR of over 17.2% during the forecast period, this technology has become pivotal due to its sensitivity and quantitative capabilities. The demand for qPCR kits has surged, especially for COVID-19 diagnostics, allowing for high-sensitivity identification of SARS-CoV-2, analysis of viral RNA, detection of mutations, and assessment of antiviral medicines. The ongoing pandemic has accelerated the adoption of qPCR, establishing it as a cornerstone in RNA analysis.

Market Valuation and Growth Projections

The global RNA Analysis Market is anticipated to grow from $16.2 billion in 2024 to $53.4 billion by 2031. This remarkable growth trajectory underscores the increasing importance and application of RNA analysis in various fields, including medical diagnostics and biotechnology.

Factors Driving Demand

The demand for RNA analysis is propelled by several factors, including the rising emphasis on tailored medication in cancer treatment and increased R&D spending in technologies like qPCR, microarray, and sequencing. Additionally, the development of biomarkers and toxicogenomic research, coupled with a growing interest in outsourcing services, presents substantial opportunities for market participants. The private sector's expansion in transcriptomics research, especially in North America, further boosts market growth.

Regional Insights

North America: North America continues to dominate the RNA Analysis Market, largely due to significant investments in transcriptomics-related research and development. The region's well-established biotech infrastructure, coupled with a robust network of academic and research institutions, provides a strong foundation for ongoing innovation and commercialization of advanced RNA analysis technologies. The presence of numerous leading biotech and pharmaceutical companies further enhances the region's market position. Additionally, North America benefits from substantial government funding and private sector investments aimed at advancing genomic and transcriptomic research. These factors collectively drive high demand for RNA analysis solutions, fostering market growth and technological advancements.

Asia Pacific: The Asia Pacific region is poised for rapid growth in the RNA Analysis Market, projected to expand at the fastest rate during the forecast period. This growth is fueled by increased expenditure on RNA analysis in countries such as South Korea, Japan, and China. These countries are making significant investments in pharmaceutical and biopharmaceutical research and development, aiming to become global leaders in biotechnology innovation. The region's dynamic market environment is characterized by a surge in product innovations, the establishment of cutting-edge research facilities, and a growing emphasis on personalized medicine. Furthermore, supportive government policies, rising healthcare expenditures, and an expanding base of skilled researchers and scientists are contributing to the rapid adoption and advancement of RNA analysis technologies across the Asia Pacific. These elements are expected to drive substantial market expansion and position the region as a key player in the global RNA analysis landscape.

Key Market Players

Prominent companies driving the RNA Analysis Market include Agilent Technologies Inc, Bio-Rad Laboratories Inc, F. Hoffman-La Roche Ltd, Illumina Inc, QIAGEN, Thermo Fisher Scientific, Danaher Corporation, and Lexogen GmbH. These players are continuously engaging in strategic alliances, partnerships, acquisitions, and mergers to enhance their market presence and technological capabilities.

Recent Developments

Qiagen: Launched the QIAseq DIRECT SARS-CoV-2 Kit, designed for viral library preparation and genomic enrichment to meet the rising demand for high-throughput sequencing.
Thermo Fisher Scientific: Introduced the TaqPath Covid-19 RNase P 2.0 test kit, marked CE-IVD, which detects active SARS-CoV-2 by identifying eight gene targets, ensuring reliable results for current and future virus variants.
Agilent Technologies: Completed the acquisition of Resolution Bioscience, enhancing its capabilities in liquid biopsy-based diagnostics and expanding its diagnostics and genomics businesses.

Market Segments Covered in RNA Analysis Market Analysis

By Product Type

Instruments
Kits & Reagents
- miRNA & siRNA
- Reverse Transcriptases & RT-PCR
- RNA Extraction & Purification
- RNA Interference
- Others
Services

By Technology

Real Time-PCR (qPCR) Technology
Microarray Technology
Sequencing Technology
Others

By Application

Construction of RNA Expression Atlas
Epigenetics
Infectious Diseases and Pathogenesis
Alternative RNA Splicing
RNA Structure & Molecular Dynamics
Development & Delivery of RNA Therapeutics
Others

By End-use

Government Institutes & Academic Centers
Pharmaceutical & Biotechnology Companies
Contract Research Organizations (CROs)
Hospitals & Clinics

By Region

North America
Latin America
Europe
APAC
MEA

1. Executive Summary

1.1. Global RNA Analysis Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2024
1.5. Analyst Recommendations

2. Market Overview

2.1. Market Definitions and Segmentations
2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter's Five Forces Analysis
2.5. COVID-19 Impact Analysis
- 2.5.1. Supply
- 2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
- 2.7.1. World Economic Projections
2.8. PESTLE Analysis

3. Global RNA Analysis Market Outlook, 2018 - 2031

3.1. Global RNA Analysis Market Outlook, By Product Type, Value (US$ Bn), 2018 - 2031
- 3.1.1. Key Highlights
  - 3.1.1.1. Instruments
  - 3.1.1.2. Kits & Reagents
    - 3.1.1.2.1. miRNA & siRNA
    - 3.1.1.2.2. Reverse Transcriptase & RT-PCR
    - 3.1.1.2.3. RNA Extraction & Purification
    - 3.1.1.2.4. RNA Interference
    - 3.1.1.2.5. Others
  - 3.1.1.3. Services
3.2. Global RNA Analysis Market Outlook, By Technology, Value (US$ Bn), 2018 - 2031
- 3.2.1. Key Highlights
  - 3.2.1.1. Real Time-PCR (qPCR) Technology
  - 3.2.1.2. Microarray Technology
  - 3.2.1.3. Sequencing Technology
  - 3.2.1.4. Others
3.3. Global RNA Analysis Market Outlook, By Application, Value (US$ Bn), 2018 - 2031
- 3.3.1. Key Highlights
  - 3.3.1.1. Construction of RNA Expression Atlas
  - 3.3.1.2. Epigenetics
  - 3.3.1.3. Infectious Diseases and Pathogenesis
  - 3.3.1.4. Alternative RNA Splicing
  - 3.3.1.5. RNA Structure & Molecular Dynamics
  - 3.3.1.6. Development & Delivery of RNA Therapeutics
  - 3.3.1.7. Others
3.4. Global RNA Analysis Market Outlook, By End-use, Value (US$ Bn), 2018 - 2031
- 3.4.1. Key Highlights
  - 3.4.1.1. Government Institutes & Academic Centers
  - 3.4.1.2. Pharmaceutical & Biotechnology Companies
  - 3.4.1.3. Contract Research Organizations (CROs)
  - 3.4.1.4. Hospitals & Clinics
3.5. Global RNA Analysis Market Outlook, by Region, Value (US$ Bn), 2018 - 2031
- 3.5.1. Key Highlights
  - 3.5.1.1. North America
  - 3.5.1.2. Europe
  - 3.5.1.3. Asia Pacific
  - 3.5.1.4. Latin America
  - 3.5.1.5. Middle East & Africa

4. North America RNA Analysis Market Outlook, 2018 - 2031

4.1. North America RNA Analysis Market Outlook, By Product Type, Value (US$ Bn), 2018 - 2031
- 4.1.1. Key Highlights
  - 4.1.1.1. Instruments
  - 4.1.1.2. Kits & Reagents
    - 4.1.1.2.1. miRNA & siRNA
    - 4.1.1.2.2. Reverse Transcriptase & RT-PCR
    - 4.1.1.2.3. RNA Extraction & Purification
    - 4.1.1.2.4. RNA Interference
    - 4.1.1.2.5. Others
  - 4.1.1.3. Services
4.2. North America RNA Analysis Market Outlook, By Technology, Value (US$ Bn), 2018 - 2031
- 4.2.1. Key Highlights
  - 4.2.1.1. Real Time-PCR (qPCR) Technology
  - 4.2.1.2. Microarray Technology
  - 4.2.1.3. Sequencing Technology
  - 4.2.1.4. Others
4.3. North America RNA Analysis Market Outlook, By Application, Value (US$ Bn), 2018 - 2031
- 4.3.1. Key Highlights
  - 4.3.1.1. Construction of RNA Expression Atlas
  - 4.3.1.2. Epigenetics
  - 4.3.1.3. Infectious Diseases and Pathogenesis
  - 4.3.1.4. Alternative RNA Splicing
  - 4.3.1.5. RNA Structure & Molecular Dynamics
  - 4.3.1.6. Development & Delivery of RNA Therapeutics
  - 4.3.1.7. Others
4.4. North America RNA Analysis Market Outlook, By End-use, Value (US$ Bn), 2018 - 2031
- 4.4.1. Key Highlights
  - 4.4.1.1. Government Institutes & Academic Centers
  - 4.4.1.2. Pharmaceutical & Biotechnology Companies
  - 4.4.1.3. Contract Research Organizations (CROs)
  - 4.4.1.4. Hospitals & Clinics
4.5. North America RNA Analysis Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
- 4.5.1. Key Highlights
  - 4.5.1.1. U.S. RNA Analysis Market By Product Type, Value (US$ Bn), 2018 - 2031
  - 4.5.1.2. U.S. RNA Analysis Market By Technology, Value (US$ Bn), 2018 - 2031
  - 4.5.1.3. U.S. RNA Analysis Market By Application, Value (US$ Bn), 2018 - 2031
  - 4.5.1.4. U.S. RNA Analysis Market By End-use, Value (US$ Bn), 2018 - 2031
  - 4.5.1.5. Canada RNA Analysis Market By Product Type, Value (US$ Bn), 2018 - 2031
  - 4.5.1.6. Canada RNA Analysis Market By Technology, Value (US$ Bn), 2018 - 2031
  - 4.5.1.7. Canada RNA Analysis Market By Application, Value (US$ Bn), 2018 - 2031
  - 4.5.1.8. Canada RNA Analysis Market By End-use, Value (US$ Bn), 2018 - 2031
- 4.5.2. Market Attractiveness Analysis

5. Europe RNA Analysis Market Outlook, 2018 - 2031

5.1. Europe RNA Analysis Market Outlook, By Product Type, Value (US$ Bn), 2018 - 2031
- 5.1.1. Key Highlights
  - 5.1.1.1. Instruments
  - 5.1.1.2. Kits & Reagents
    - 5.1.1.2.1. miRNA & siRNA
    - 5.1.1.2.2. Reverse Transcriptase & RT-PCR
    - 5.1.1.2.3. RNA Extraction & Purification
    - 5.1.1.2.4. RNA Interference
    - 5.1.1.2.5. Others
  - 5.1.1.3. Services
5.2. Europe RNA Analysis Market Outlook, By Technology, Value (US$ Bn), 2018 - 2031
- 5.2.1. Key Highlights
  - 5.2.1.1. Real Time-PCR (qPCR) Technology
  - 5.2.1.2. Microarray Technology
  - 5.2.1.3. Sequencing Technology
  - 5.2.1.4. Others
5.3. Europe RNA Analysis Market Outlook, By Application, Value (US$ Bn), 2018 - 2031
- 5.3.1. Key Highlights
  - 5.3.1.1. Construction of RNA Expression Atlas
  - 5.3.1.2. Epigenetics
  - 5.3.1.3. Infectious Diseases and Pathogenesis
  - 5.3.1.4. Alternative RNA Splicing
  - 5.3.1.5. RNA Structure & Molecular Dynamics
  - 5.3.1.6. Development & Delivery of RNA Therapeutics
  - 5.3.1.7. Others
5.4. Europe RNA Analysis Market Outlook, By End-use, Value (US$ Bn), 2018 - 2031
- 5.4.1. Key Highlights
  - 5.4.1.1. Government Institutes & Academic Centers
  - 5.4.1.2. Pharmaceutical & Biotechnology Companies
  - 5.4.1.3. Contract Research Organizations (CROs)
  - 5.4.1.4. Hospitals & Clinics
5.5. Europe RNA Analysis Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
- 5.5.1. Key Highlights
  - 5.5.1.1. Germany RNA Analysis Market By Product Type, Value (US$ Bn), 2018 - 2031
  - 5.5.1.2. Germany RNA Analysis Market By Technology, Value (US$ Bn), 2018 - 2031
  - 5.5.1.3. Germany RNA Analysis Market By Application, Value (US$ Bn), 2018 - 2031
  - 5.5.1.4. Germany RNA Analysis Market By End-use, Value (US$ Bn), 2018 - 2031
  - 5.5.1.5. U.K. RNA Analysis Market By Product Type, Value (US$ Bn), 2018 - 2031
  - 5.5.1.6. U.K. RNA Analysis Market By Technology, Value (US$ Bn), 2018 - 2031
  - 5.5.1.7. U.K. RNA Analysis Market By Application, Value (US$ Bn), 2018 - 2031
  - 5.5.1.8. U.K. RNA Analysis Market By End-use, Value (US$ Bn), 2018 - 2031
  - 5.5.1.9. France RNA Analysis Market By Product Type, Value (US$ Bn), 2018 - 2031
  - 5.5.1.10. France RNA Analysis Market By Technology, Value (US$ Bn), 2018 - 2031
  - 5.5.1.11. France RNA Analysis Market By Application, Value (US$ Bn), 2018 - 2031
  - 5.5.1.12. France RNA Analysis Market By End-use, Value (US$ Bn), 2018 - 2031
  - 5.5.1.13. Italy RNA Analysis Market By Product Type, Value (US$ Bn), 2018 - 2031
  - 5.5.1.14. Italy RNA Analysis Market By Technology, Value (US$ Bn), 2018 - 2031
  - 5.5.1.15. Italy RNA Analysis Market By Application, Value (US$ Bn), 2018 - 2031
  - 5.5.1.16. Italy RNA Analysis Market By End-use, Value (US$ Bn), 2018 - 2031
  - 5.5.1.17. Turkey RNA Analysis Market By Product Type, Value (US$ Bn), 2018 - 2031
  - 5.5.1.18. Turkey RNA Analysis Market By Technology, Value (US$ Bn), 2018 - 2031
  - 5.5.1.19. Turkey RNA Analysis Market By Application, Value (US$ Bn), 2018 - 2031
  - 5.5.1.20. Turkey RNA Analysis Market By Application, Value (US$ Bn), 2018 - 2031
  - 5.5.1.21. Russia RNA Analysis Market By Product Type, Value (US$ Bn), 2018 - 2031
  - 5.5.1.22. Russia RNA Analysis Market By Technology, Value (US$ Bn), 2018 - 2031
  - 5.5.1.23. Russia RNA Analysis Market By Application, Value (US$ Bn), 2018 - 2031
  - 5.5.1.24. Russia RNA Analysis Market By Application, Value (US$ Bn), 2018 - 2031
  - 5.5.1.25. Rest of Europe RNA Analysis Market By Product Type, Value (US$ Bn), 2018 - 2031
  - 5.5.1.26. Rest of Europe RNA Analysis Market By Technology, Value (US$ Bn), 2018 - 2031
  - 5.5.1.27. Rest of Europe RNA Analysis Market By Application, Value (US$ Bn), 2018 - 2031
  - 5.5.1.28. Rest of Europe RNA Analysis Market By Application, Value (US$ Bn), 2018 - 2031
- 5.5.2. Market Attractiveness Analysis

6. Asia Pacific RNA Analysis Market Outlook, 2018 - 2031

6.1. Asia Pacific RNA Analysis Market Outlook, By Product Type, Value (US$ Bn), 2018 - 2031
- 6.1.1. Key Highlights
  - 6.1.1.1. Instruments
  - 6.1.1.2. Kits & Reagents
    - 6.1.1.2.1. miRNA & siRNA
    - 6.1.1.2.2. Reverse Transcriptase & RT-PCR
    - 6.1.1.2.3. RNA Extraction & Purification
    - 6.1.1.2.4. RNA Interference
    - 6.1.1.2.5. Others
  - 6.1.1.3. Services
6.2. Asia Pacific RNA Analysis Market Outlook, By Technology, Value (US$ Bn), 2018 - 2031
- 6.2.1. Key Highlights
  - 6.2.1.1. Real Time-PCR (qPCR) Technology
  - 6.2.1.2. Microarray Technology
  - 6.2.1.3. Sequencing Technology
  - 6.2.1.4. Others
6.3. Asia Pacific RNA Analysis Market Outlook, By Application, Value (US$ Bn), 2018 - 2031
- 6.3.1. Key Highlights
  - 6.3.1.1. Construction of RNA Expression Atlas
  - 6.3.1.2. Epigenetics
  - 6.3.1.3. Infectious Diseases and Pathogenesis
  - 6.3.1.4. Alternative RNA Splicing
  - 6.3.1.5. RNA Structure & Molecular Dynamics
  - 6.3.1.6. Development & Delivery of RNA Therapeutics
  - 6.3.1.7. Others
6.4. Asia Pacific RNA Analysis Market Outlook, By End-use, Value (US$ Bn), 2018 - 2031
- 6.4.1. Key Highlights
  - 6.4.1.1. Government Institutes & Academic Centers
  - 6.4.1.2. Pharmaceutical & Biotechnology Companies
  - 6.4.1.3. Contract Research Organizations (CROs)
  - 6.4.1.4. Hospitals & Clinics
6.5. Asia Pacific RNA Analysis Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
- 6.5.1. Key Highlights
  - 6.5.1.1. China RNA Analysis Market By Product Type, Value (US$ Bn), 2018 - 2031
  - 6.5.1.2. China RNA Analysis Market By Technology, Value (US$ Bn), 2018 - 2031
  - 6.5.1.3. China RNA Analysis Market By Application, Value (US$ Bn), 2018 - 2031
  - 6.5.1.4. China RNA Analysis Market By End-use, Value (US$ Bn), 2018 - 2031
  - 6.5.1.5. Japan RNA Analysis Market By Product Type, Value (US$ Bn), 2018 - 2031
  - 6.5.1.6. Japan RNA Analysis Market By Technology, Value (US$ Bn), 2018 - 2031
  - 6.5.1.7. Japan RNA Analysis Market By Application, Value (US$ Bn), 2018 - 2031
  - 6.5.1.8. Japan RNA Analysis Market By End-use, Value (US$ Bn), 2018 - 2031
  - 6.5.1.9. South Korea RNA Analysis Market By Product Type, Value (US$ Bn), 2018 - 2031
  - 6.5.1.10. South Korea RNA Analysis Market By Technology, Value (US$ Bn), 2018 - 2031
  - 6.5.1.11. South Korea RNA Analysis Market By Application, Value (US$ Bn), 2018 - 2031
  - 6.5.1.12. South Korea RNA Analysis Market By End-use, Value (US$ Bn), 2018 - 2031
  - 6.5.1.13. India RNA Analysis Market By Product Type, Value (US$ Bn), 2018 - 2031
  - 6.5.1.14. India RNA Analysis Market By Technology, Value (US$ Bn), 2018 - 2031
  - 6.5.1.15. India RNA Analysis Market By Application, Value (US$ Bn), 2018 - 2031
  - 6.5.1.16. India RNA Analysis Market By End-use, Value (US$ Bn), 2018 - 2031
  - 6.5.1.17. Southeast Asia RNA Analysis Market By Product Type, Value (US$ Bn), 2018 - 2031
  - 6.5.1.18. Southeast Asia RNA Analysis Market By Technology, Value (US$ Bn), 2018 - 2031
  - 6.5.1.19. Southeast Asia RNA Analysis Market By Application, Value (US$ Bn), 2018 - 2031
  - 6.5.1.20. Southeast Asia RNA Analysis Market By End-use, Value (US$ Bn), 2018 - 2031
  - 6.5.1.21. Rest of Asia Pacific RNA Analysis Market By Product Type, Value (US$ Bn), 2018 - 2031
  - 6.5.1.22. Rest of Asia Pacific RNA Analysis Market By Technology, Value (US$ Bn), 2018 - 2031
  - 6.5.1.23. Rest of Asia Pacific RNA Analysis Market By Application, Value (US$ Bn), 2018 - 2031
  - 6.5.1.24. Rest of Asia Pacific RNA Analysis Market By End-use, Value (US$ Bn), 2018 - 2031
- 6.5.2. Market Attractiveness Analysis

7. Latin America RNA Analysis Market Outlook, 2018 - 2031

7.1. Latin America RNA Analysis Market Outlook, By Product Type, Value (US$ Bn), 2018 - 2031
- 7.1.1. Key Highlights
  - 7.1.1.1. Instruments
  - 7.1.1.2. Kits & Reagents
    - 7.1.1.2.1. miRNA & siRNA
    - 7.1.1.2.2. Reverse Transcriptase & RT-PCR
    - 7.1.1.2.3. RNA Extraction & Purification
    - 7.1.1.2.4. RNA Interference
    - 7.1.1.2.5. Others
  - 7.1.1.3. Services
7.2. Latin America RNA Analysis Market Outlook, By Technology, Value (US$ Bn), 2018 - 2031
- 7.2.1. Key Highlights
  - 7.2.1.1. Real Time-PCR (qPCR) Technology
  - 7.2.1.2. Microarray Technology
  - 7.2.1.3. Sequencing Technology
  - 7.2.1.4. Others
7.3. Latin America RNA Analysis Market Outlook, By Application, Value (US$ Bn), 2018 - 2031
- 7.3.1. Key Highlights
  - 7.3.1.1. Construction of RNA Expression Atlas
  - 7.3.1.2. Epigenetics
  - 7.3.1.3. Infectious Diseases and Pathogenesis
  - 7.3.1.4. Alternative RNA Splicing
  - 7.3.1.5. RNA Structure & Molecular Dynamics
  - 7.3.1.6. Development & Delivery of RNA Therapeutics
  - 7.3.1.7. Others
7.4. Latin America RNA Analysis Market Outlook, By End-use, Value (US$ Bn), 2018 - 2031
- 7.4.1. Key Highlights
  - 7.4.1.1. Government Institutes & Academic Centers
  - 7.4.1.2. Pharmaceutical & Biotechnology Companies
  - 7.4.1.3. Contract Research Organizations (CROs)
  - 7.4.1.4. Hospitals & Clinics
7.5. Latin America RNA Analysis Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
- 7.5.1. Key Highlights
  - 7.5.1.1. Brazil RNA Analysis Market By Product Type, Value (US$ Bn), 2018 - 2031
  - 7.5.1.2. Brazil RNA Analysis Market By Technology, Value (US$ Bn), 2018 - 2031
  - 7.5.1.3. Brazil RNA Analysis Market By Application, Value (US$ Bn), 2018 - 2031
  - 7.5.1.4. Brazil RNA Analysis Market By End-use, Value (US$ Bn), 2018 - 2031
  - 7.5.1.5. Mexico RNA Analysis Market By Product Type, Value (US$ Bn), 2018 - 2031
  - 7.5.1.6. Mexico RNA Analysis Market By Technology, Value (US$ Bn), 2018 - 2031
  - 7.5.1.7. Mexico RNA Analysis Market By Application, Value (US$ Bn), 2018 - 2031
  - 7.5.1.8. Mexico RNA Analysis Market By End-use, Value (US$ Bn), 2018 - 2031
  - 7.5.1.9. Argentina RNA Analysis Market By Product Type, Value (US$ Bn), 2018 - 2031
  - 7.5.1.10. Argentina RNA Analysis Market By Technology, Value (US$ Bn), 2018 - 2031
  - 7.5.1.11. Argentina RNA Analysis Market By Application, Value (US$ Bn), 2018 - 2031
  - 7.5.1.12. Argentina RNA Analysis Market By End-use, Value (US$ Bn), 2018 - 2031
  - 7.5.1.13. Rest of Latin America RNA Analysis Market By Product Type, Value (US$ Bn), 2018 - 2031
  - 7.5.1.14. Rest of Latin America RNA Analysis Market By Technology, Value (US$ Bn), 2018 - 2031
  - 7.5.1.15. Rest of Latin America RNA Analysis Market By Application, Value (US$ Bn), 2018 - 2031
  - 7.5.1.16. Rest of Latin America RNA Analysis Market By End-use, Value (US$ Bn), 2018 - 2031
- 7.5.2. Market Attractiveness Analysis

8. Middle East & Africa RNA Analysis Market Outlook, 2018 - 2031

8.1. Middle East & Africa RNA Analysis Market Outlook, By Product Type, Value (US$ Bn), 2018 - 2031
- 8.1.1. Key Highlights
  - 8.1.1.1. Instruments
  - 8.1.1.2. Kits & Reagents
    - 8.1.1.2.1. miRNA & siRNA
    - 8.1.1.2.2. Reverse Transcriptase & RT-PCR
    - 8.1.1.2.3. RNA Extraction & Purification
    - 8.1.1.2.4. RNA Interference
    - 8.1.1.2.5. Others
  - 8.1.1.3. Services
8.2. Middle East & Africa RNA Analysis Market Outlook, By Technology, Value (US$ Bn), 2018 - 2031
- 8.2.1. Key Highlights
  - 8.2.1.1. Real Time-PCR (qPCR) Technology
  - 8.2.1.2. Microarray Technology
  - 8.2.1.3. Sequencing Technology
  - 8.2.1.4. Others
8.3. Middle East & Africa RNA Analysis Market Outlook, By Application, Value (US$ Bn), 2018 - 2031
- 8.3.1. Key Highlights
  - 8.3.1.1. Construction of RNA Expression Atlas
  - 8.3.1.2. Epigenetics
  - 8.3.1.3. Infectious Diseases and Pathogenesis
  - 8.3.1.4. Alternative RNA Splicing
  - 8.3.1.5. RNA Structure & Molecular Dynamics
  - 8.3.1.6. Development & Delivery of RNA Therapeutics
  - 8.3.1.7. Others
8.4. Middle East & Africa RNA Analysis Market Outlook, By End-use, Value (US$ Bn), 2018 - 2031
- 8.4.1. Key Highlights
  - 8.4.1.1. Government Institutes & Academic Centers
  - 8.4.1.2. Pharmaceutical & Biotechnology Companies
  - 8.4.1.3. Contract Research Organizations (CROs)
  - 8.4.1.4. Hospitals & Clinics
8.5. Middle East & Africa RNA Analysis Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
- 8.5.1. Key Highlights
  - 8.5.1.1. GCC RNA Analysis Market By Product Type, Value (US$ Bn), 2018 - 2031
  - 8.5.1.2. GCC RNA Analysis Market By Technology, Value (US$ Bn), 2018 - 2031
  - 8.5.1.3. GCC RNA Analysis Market By Application, Value (US$ Bn), 2018 - 2031
  - 8.5.1.4. GCC RNA Analysis Market By End-use, Value (US$ Bn), 2018 - 2031
  - 8.5.1.5. South Africa RNA Analysis Market By Product Type, Value (US$ Bn), 2018 - 2031
  - 8.5.1.6. South Africa RNA Analysis Market By Technology, Value (US$ Bn), 2018 - 2031
  - 8.5.1.7. South Africa RNA Analysis Market By Application, Value (US$ Bn), 2018 - 2031
  - 8.5.1.8. South Africa RNA Analysis Market By End-use, Value (US$ Bn), 2018 - 2031
  - 8.5.1.9. Egypt RNA Analysis Market By Product Type, Value (US$ Bn), 2018 - 2031
  - 8.5.1.10. Egypt RNA Analysis Market By Technology, Value (US$ Bn), 2018 - 2031
  - 8.5.1.11. Egypt RNA Analysis Market By Application, Value (US$ Bn), 2018 - 2031
  - 8.5.1.12. Egypt RNA Analysis Market By End-use, Value (US$ Bn), 2018 - 2031
  - 8.5.1.13. Nigeria RNA Analysis Market By Product Type, Value (US$ Bn), 2018 - 2031
  - 8.5.1.14. Nigeria RNA Analysis Market By Technology, Value (US$ Bn), 2018 - 2031
  - 8.5.1.15. Nigeria RNA Analysis Market By Application, Value (US$ Bn), 2018 - 2031
  - 8.5.1.16. Nigeria RNA Analysis Market By End-use, Value (US$ Bn), 2018 - 2031
  - 8.5.1.17. Rest of Middle East & Africa RNA Analysis Market By Product Type, Value (US$ Bn), 2018 - 2031
  - 8.5.1.18. Rest of Middle East & Africa RNA Analysis Market By Technology, Value (US$ Bn), 2018 - 2031
  - 8.5.1.19. Rest of Middle East & Africa RNA Analysis Market By Application, Value (US$ Bn), 2018 - 2031
  - 8.5.1.20. Rest of Middle East & Africa RNA Analysis Market By End-use, Value (US$ Bn), 2018 - 2031
- 8.5.2. Market Attractiveness Analysis

9. Competitive Landscape

9.1. By Application vs By Technology Heatmap
9.2. Company Market Share Analysis, 2023
9.3. Competitive Dashboard
9.4. Company Profiles
- 9.4.1. Agilent Technologies Inc
  - 9.4.1.1. Company Overview
  - 9.4.1.2. Product Portfolio
  - 9.4.1.3. Financial Overview
  - 9.4.1.4. Business Strategies and Development
- 9.4.2. Bio-Rad Laboratories Inc
  - 9.4.2.1. Company Overview
  - 9.4.2.2. Product Portfolio
  - 9.4.2.3. Financial Overview
  - 9.4.2.4. Business Strategies and Development
- 9.4.3. F.Hoffman-La Roche Ltd
  - 9.4.3.1. Company Overview
  - 9.4.3.2. Product Portfolio
  - 9.4.3.3. Financial Overview
  - 9.4.3.4. Business Strategies and Development
- 9.4.4. IllUMINA Inc
  - 9.4.4.1. Company Overview
  - 9.4.4.2. Product Portfolio
  - 9.4.4.3. Financial Overview
  - 9.4.4.4. Business Strategies and Development
- 9.4.5. QIAGEN
  - 9.4.5.1. Company Overview
  - 9.4.5.2. Product Portfolio
  - 9.4.5.3. Financial Overview
  - 9.4.5.4. Business Strategies and Development
- 9.4.6. Thermo Fisher Scientific
  - 9.4.6.1. Company Overview
  - 9.4.6.2. Product Portfolio
  - 9.4.6.3. Financial Overview
  - 9.4.6.4. Business Strategies and Development
- 9.4.7. Danaher Corporation
  - 9.4.7.1. Company Overview
  - 9.4.7.2. Product Portfolio
  - 9.4.7.3. Financial Overview
  - 9.4.7.4. Business Strategies and Development
- 9.4.8. Lexogen GmbH
  - 9.4.8.1. Company Overview
  - 9.4.8.2. Product Portfolio
  - 9.4.8.3. Financial Overview
  - 9.4.8.4. Business Strategies and Development
- 9.4.9. Eurofins Scientific
  - 9.4.9.1. Company Overview
  - 9.4.9.2. Product Portfolio
  - 9.4.9.3. Financial Overview
  - 9.4.9.4. Business Strategies and Development
- 9.4.10. Merck KGaA
  - 9.4.10.1. Company Overview
  - 9.4.10.2. Product Portfolio
  - 9.4.10.3. Financial Overview
  - 9.4.10.4. Business Strategies and Development

10. Appendix

10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations